Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Nordic Studies on Alcohol and Drugs

The Journal of Nordic Centre for Welfare and Social Issues

6 Issues per year


IMPACT FACTOR 2016: 0.746

CiteScore 2016: 0.54

SCImago Journal Rank (SJR) 2015: 0.321
Source Normalized Impact per Paper (SNIP) 2015: 0.485

Open Access
Online
ISSN
1458-6126
See all formats and pricing
In This Section
Ahead of print

Issues

Anabolic-androgenic Steroid Use in the Nordic Countries: A Meta-analysis and Meta-regression Analysis

Dominic Sagoe
  • Department of Psychosocial Science, University of Bergen, Norway
  • Email:
/ Torbjørn Torsheim
  • Department of Psychosocial Science, University of Bergen, Norway
  • Email:
/ Helge Molde
  • Department of Clinical Psychology, University of Bergen, Norway
  • Email:
/ Cecilie Schou Andreassen
  • Department of Psychosocial Science, University of Bergen, Norway
  • The Competence Center, Bergen Clinics Foundation, Norway
  • Email:
/ Ståle Pallesen
  • Department of Psychosocial Science, University of Bergen, Norway
  • Email:
Published Online: 2014-12-16 | DOI: https://doi.org/10.2478/nsad-2014-0037

Abstract

AIMS – To investigate the lifetime prevalence and moderators of non-medical AAS use in the five Nordic countries. METHODS – We conducted a meta-analysis and meta-regression using studies gathered from searches in PsycINFO, PubMed, ISI Web of Science, Google Scholar, and reference checks. Included were 32 studies that provided original data on 48 lifetime prevalence rates based on a total of 233,475 inhabitants of the Nordic countries. RESULTS – The overall lifetime prevalence obtained was 2.1% [95% confidence interval (CI): 1.3-3.4, I 2 = 99.5, P < 0.001]. The prevalence for males, 2.9% (95% CI: 1.7-4.8, I 2 = 99.2, P < 0.001), was significantly higher (Qbet = 40.5, P < 0.001) than the rate for females, 0.2% (95% CI: 0.1-0.4, I 2 = 90.5, P < 0.001). Sweden has the highest prevalence of AAS use: 4.4%, followed by Norway: 2.4%, Finland: 0.8%, Iceland: 0.7%, and Denmark: 0.5%. Country, sample type, and male sample percentage significantly predicted AAS use prevalence in a meta-regression analysis. No indication of publication bias was found. CONCLUSION – Though subject to some limitations, our findings suggest that non-medical AAS use should be regarded as a serious public health problem in the Nordic countries.

Keywords: anabolic steroids; Nordic countries; Scandinavia; prevalence; meta-analysis; meta-regression

References

  • Andrade, A. G., Duarte, P. C. A. V., Barroso, L. P., Nishimura, R., Alberghini, D. G., & Oliveira, L. G. (2012). Use of alcohol and other drugs among Brazilian college students: Effects of gender and age. Revista Brasileira de Psiquiatria, 34(3), 294–305. [Crossref]

  • Bahrke, M. S., & Yesalis, C.E. (2004). Abuse of anabolic androgenic steroids and related substances in sport and exercise. Current Opinion in Pharmacology, 4(6), 614–620. [Crossref]

  • Baker, J. S., Thomas, N. E., Davies, B., & Graham, M. R. (2008). Anabolic androgenic steroid (AAS) abuse: Not only an elite performance issue? Open Sports Medicine Journal, 2, 38–39.

  • Biostat Inc. (2014). Comprehensive Meta- Analysis Version 3.0. Englewood, NJ.: Biostat Inc.

  • Bojsen-Møller, J., & Christiansen, A. V. (2010). Use of performance-and image-enhancing substances among recreational athletes: A quantitative analysis of inquiries submitted to the Danish anti-doping authorities. Scandinavian Journal of Medicine and Science in Sports, 20(6), 861–867. [Crossref]

  • Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2009). Introduction to Meta- Analysis. Chichester, West Sussex: Wiley- Blackwell.

  • Boyadjiev, N., Georgieva, K., Massaldjieva, R., & Gueorguiev, S. (2000). Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report. Journal of Sports Medicine and Physical Fitness, 40(3), 271–274.

  • Calabria, B., Degenhardt, L., Nelson, P., Bucello, C., Lynskey, M., Hall, W., Roberts, A., & McLaren, J. (2009). Methodology used in a systematic review of evidence on the prevalence of cannabis use and dependence. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group. Illicit drugs discussion paper No. 14. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.

  • Degenhardt, L., & Hall, W. (2012). The extent of illicit drug use, dependence, and their contribution to global burden of disease. Lancet, 379(9810), 55–70. [Crossref] [PubMed]

  • Dodge, T., & Hoagland, M. F. (2011). The use of anabolic androgenic steroids and polypharmacy: a review of the literature. Drug and Alcohol Dependence, 114(2-3), 100–109.

  • Dodge, T. L., & Jaccard, J. J. (2006). The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. Journal of Adolescent Health, 39(3), 367–373. [Crossref]

  • Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463. [PubMed] [Crossref]

  • Gårevik, N., & Rane, A. (2010). Dual use of anabolic-androgenic steroids and narcotics in Sweden. Drug and Alcohol Dependence, 109(1), 144–146. [Crossref]

  • Gmel, G., & Daeppen, J. B. (2007). Recall bias for seven-day recall measurement of alcohol consumption among emergency department patients: Implications for case-crossover designs. Journal of Studies on Alcohol and Drugs, 68, 303–310.

  • Grace, F., Baker, J., & Davies, B. (2001). Anabolic androgenic steroid use in recreational gym users: a regional sample of the Mid-Glamorgan area. Journal of Substance Use, 6(3), 189–195.

  • Hakansson, A., Mickelsson, K., Wallin, C., & Berglund, M. (2012). Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. European Addiction Research, 18(2), 83–90. [PubMed] [Crossref]

  • Haug, J., & Ingvaldsen, R. (1974). Noen synspunkter pa bruken av hormonpreparater blant aktive idrettsutøvere [Some views on the use of hormone drugs among active athletes]. Oslo: Institute of Psychology, University of Oslo.

  • Hibell, B., Anderson, B., Ahlström, S., Balakieva, O., Bjarnason, T., Kokkevi, A., & Morgan, M. (2000). The 1999 ESPAD report. Alcohol and other drug use among students in 30 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs (CAN).

  • Hibell, B., Anderson, B., Bjarnason, T., Ahlström, S., Balakieva, O., Kokkevi, A., & Morgan, M. (2004). The ESPAD Report 2003. Alcohol and other drug use among students in 35 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs (CAN).

  • Hibell, B., Andersson, B., Bjarnason, T., Kokkevi, A., Morgan, M., & Narusk, A. (1997). Alcohol and other drug use among students in 26 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs (CAN) and the Pompidou Group at the Council of Europe.

  • Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., & Kraus, L. (2012). The 2011 ESPAD report: substance use among students in 36 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs (CAN).

  • Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., & Kraus, L. (2007). The 2007 ESPAD report. Substance use among students in 35 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs (CAN), The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

  • Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., & Kraus, L. (2009). The 2007 ESPAD report. Substance use among students in 35 European countries. The Swedish Council for Information on Alcohol and Other Drugs, Stockholm, Sweden.

  • Hoffman, J. R., & Ratamess, N.A. (2006). Medical issues associated with anabolic steroid use: are they exaggerated. Journal of Sports Science and Medicine, 5(2), 182–193.

  • Johnson, M. D., Jay, M. S., Shoup, B., & Rickert, V.I. (1989). Anabolic steroid use by male adolescents. Pediatrics, 83(6), 921–924. [PubMed]

  • Kanayama, G., Boynes, M., Hudson, J. I., Field, A. E., & Pope Jr., H. G., (2007). Anabolic steroid abuse among teenage girls: An illusory problem? Drug and Alcohol Dependence, 88, 156–162. [Crossref]

  • Kanayama, G., Hudson, J. I., & Pope Jr., H. G. (2008). Long-term psychiatric and medical consequences of anabolic–androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98(1), 1–12. [Crossref]

  • Kanayama, G., Hudson, J. I., & Pope Jr., H. G. (2010). Illicit anabolic–androgenic steroid use. Hormones and Behavior, 58(1), 111–121. [Crossref] [PubMed]

  • Kanayama, G., Hudson, J. I., & Pope Jr., H. G. (2012). Culture, psychosomatics and substance abuse: The example of body image drugs. Psychotherapy and Psychosomatics, 81(2), 73–78. [Crossref] [PubMed]

  • Kindlundh, A. M., Isacson, D. G., Berglund, L., & Nyberg, F. (1998). Doping among high school students in Uppsala, Sweden: A presentation of the attitudes, distribution, side effects, and extent of use. Scandinavian Journal of Public Health, 26(1), 71–74. [Crossref]

  • Klötz, F., Petersson, A., Hoffman, O., & Thiblin, I. (2010). The significance of anabolic androgenic steroids in a Swedish prison population. Comprehensive Psychiatry, 51(3), 312–318. [Crossref]

  • Korte, T., Pykäläinen, J., & Seppälä, T. (1998). Drug abuse of Finnish male prisoners in 1995. Forensic Science International, 97(2-3), 171–183. [PubMed] [Crossref]

  • Leifman, H., Rehnman, C., Sjöblom, E., & Holgersson, S. (2011). Anabolic androgenic steroids—use and correlates among gym users—an assessment study using questionnaires and observations at gyms in the Stockholm region. International Journal of Environmental Research and Public Health 8(7), 2656–2674. [Crossref]

  • Lindqvist, A. S., Moberg, T., Eriksson, B. O., Ehrnborg, C., Rosén, T., & Fahlke, C. (2013). A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: A focus on mental health. British Journal of Sports Medicine, 47, 965–969. [Crossref] [PubMed]

  • Lindström, M., Nilsson, A., Katzman, P., Janzon, L., & Dymling, J. F. (1990). Use of anabolic-androgenic steroids among body builders—frequency and attitudes. Journal of Internal Medicine, 227(6), 407–411. [Crossref] [PubMed]

  • Ljungqvist, A. (1975). The use of anabolic steroids in top Swedish athletes. British Journal of Sports Medicine, 9(2), 82. [Crossref] [PubMed]

  • Lood, Y., Eklund, A., Garle, M., & Ahlner, J. (2012). Anabolic androgenic steroids in police cases in Sweden 1999–2009. Forensic Science International, 219(1-3), 199–204. [PubMed] [Crossref]

  • Lorang, M., Callahan, B., Cummins, K. M., Achar, S., & Brown, S. A. (2011). Anabolic androgenic steroid use in teens: Prevalence, demographics, and perception of effects. Journal of Child and Adolescent Substance Abuse, 20(4), 358–369.

  • Lundholm, L., Haggård, U., Möller, J., Hallqvist, J., & Thiblin, I. (2013). The triggering effect of alcohol and illicit drugs on violent crime in a remand prison population: A case-crossover study. Drug and Alcohol Dependence, 129(1-2), 110–115. [Crossref]

  • Lundholm, L., Käll, K., Wallin, S., & Thiblin, I. (2010). Use of anabolic androgenic steroids in substance abusers arrested for crime. Drug and Alcohol Dependence, 111(3), 222–226. [Crossref]

  • Mattila, V., Parkkari, J., Laakso, L., Pihlajamäki, H., & Rimpelä, A. (2009). Use of dietary supplements and anabolic-androgenic steroids among Finnish adolescents in 1991–2005. European Journal of Public Health, 20(3), 306–311. [PubMed]

  • Mattila, V., Rimpelä, A., Jormanainen, V., Sahi, T., & Pihlajamäki, H. (2010). Anabolic-androgenic steroid use among young Finnish males. Scandinavian Journal of Medicine and Science in Sport, 20(2), 330–335.

  • Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Medicine, 6(6), e1000097. [Crossref]

  • Nilsson, S. (1995). Androgenic anabolic steroid use among male adolescents in Falkenberg. European Journal of Clinical Pharmacology, 48, 9–11. [PubMed]

  • Nilsson, S., Baigi, A., Marklund, B., & Fridlund, B. (2001a). Trends in the misuse of androgenic anabolic steroids among boys 16-17 years old in a primary health care area in Sweden. Scandinavian Journal of Primary Health Care, 19(3), 181–182.

  • Nilsson, S., Baigi, A., Marklund, B., & Fridlund, B. (2001b). The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. European Journal of Public Health, 11(2), 195–197. [Crossref]

  • Nilsson, S., Spak, F., Marklund, B., Baigi, A., & Allebeck, P. (2005). Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Substance Use and Misuse, 40(1), 1–12.

  • Nøkleby, H. (2013). Use of doping agents and symptoms of eating disorders among male and female patients in drug addiction treatment. Nordic Studies on Alcohol and Drugs, 30(4), 331–346.

  • Pagonis, T. A., Angelopoulos, N. V., Koukoulis, G. N., & Hadjichristodoulou, C. S. (2006). Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562. [Crossref]

  • Pallesen, S., Jøsendal, O., Johnsen, B.-H., Larsen, S., & Molde, H. (2006). Anabolic steroid use in high school students. Substance Use and Misuse, 41(13), 1705–1717. [PubMed]

  • Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: a survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651. [Crossref]

  • Pope Jr., H. G., & Kanayama, G. (2012). Anabolic–androgenic steroids. In J. Verster, K. Brady, M. Galanter, & P. Conrod (Eds.), Drug abuse and addiction in medical illness: Causes, consequences and treatment (pp. 251–264). New York: Springer.

  • Pope Jr., H. G., Kanayama, G., & Hudson, J. I. (2012). Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: A cross-sectional cohort study. Biological Psychiatry, 71(3), 254– 261. [PubMed] [Crossref]

  • Pope Jr., H. G., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2013). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. American Journal of Addictions, doi: 10.1111/j.1521- 0391.2013.12118.x [Epub ahead of print] [Crossref]

  • Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014a). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398. [Crossref] [PubMed]

  • Sagoe, D., Andreassen, C. S., Molde, H., Torsheim, T., & Pallesen, S. (2014b). Prevalence and correlates of anabolic-androgenic steroid use in a nationally representative sample of 17 year-old Norwegian adolescents. Substance Use and Misuse, doi: 10.3109/10826084.2014.958859 [Epub ahead of print]. [Crossref]

  • Singhammer, J. (2013). Attitudes toward anabolic-androgenic steroids among non-competing athletes in various types of sports–a cross-sectional study. Sport Science Review, 22(1), 109–128.

  • Solberg, S. (1974). Unpublished data. In: Solberg, S., 1982. Anabolic steroids and Norwegian weightlifters. British Journal of Sports Medicine, 16(3), 169–171.

  • Striegel, H., Simon, P., Frisch, S., Roecker, K., Dietz, K., Dickhuth, H.-H., et al. (2006). Anabolic ergogenic substance users in fitness-sports: A distinct group supported by the health care system. Drug and Alcohol Dependence, 81(1), 11–19. [Crossref]

  • Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., et al. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283, 2008–2012.

  • Swedish National Institute of Public Health, & Lund University. (2009). Sub study in the Swedish National Institute of Public Health’s prevalence project with the aim of surveying narcotics use in Sweden. Unpublished study. Stockholm: Swedish National Institute of Public Health.

  • Swedish National Institute of Public Health. (1991). Lagen om förbud mot vissa dopningsmedel. [Act prohibiting certain doping substances.] Stockholm: Government of Sweden.

  • Tanner, S. M., Miller, D. W., & Alongi, C. (1995). Anabolic steroid use by adolescents: Prevalence, motives, and knowledge of risks. Clinical Journal of Sport Medicine, 5(2), 108–115. [Crossref]

  • Thorlindsson, T., & Halldorsson, V. (2010). Sport, and use of anabolic androgenic steroids among Icelandic high school students: a critical test of three perspectives. Substance Abuse Treatment, Prevention, and Policy, 5(1), 1–11.

  • Urhausen, A., Albers, T., & Kindermann, W. (2004). Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart, 90(5), 496–501. [PubMed] [Crossref]

  • Viera, A. J., & Garrett, J. M. (2005). Understanding interobserver agreement: the kappa statistic. Family Medicine, 37(5), 360–363. [PubMed]

  • Wichstrøm, L. (2006). Predictors of future anabolic androgenic steroid use. Medicine and Science in Sports and Exercise, 38(9), 1578–1583. [Crossref]

  • Wichstrøm, L., & Pedersen, W. (2001). Use of anabolic-androgenic steroids in adolescence: Winning, looking good or being bad? Journal of Studies on Alcohol, 62(1), 5–13.

  • Yesalis, C. E., & Bahrke, M.S. (2008). Anabolic-androgenic steroids. Sports Medicine, 19(5), 326–340.

About the article

Received: 2014-03-19

Accepted: 2014-05-21

Published Online: 2014-12-16



Citation Information: Nordic Studies on Alcohol and Drugs, ISSN (Online) 1458-6126, DOI: https://doi.org/10.2478/nsad-2014-0037. Export Citation

© 2014 Dominic Sagoe et. al.. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Comments (0)

Please log in or register to comment.
Log in